Details
| Titel in Übersetzung | Appraisal of resource use in the German health-care system from the perspective of the statutory health insurance |
|---|---|
| Originalsprache | Deutsch |
| Seiten (von - bis) | 19-23 |
| Seitenumfang | 5 |
| Fachzeitschrift | GESUNDHEITSWESEN |
| Jahrgang | 71 |
| Ausgabenummer | 1 |
| Frühes Online-Datum | 27 Jan. 2009 |
| Publikationsstatus | Veröffentlicht - Jan. 2009 |
Abstract
This paper gives a systematic overview of resource use that is relevant within the German health-care system from the perspective of the statutory health insurance and how these resource uses should be priced in economic analyses. This includes all relevant cost domains from ambulatory and inpatient care as well as a detailed description of relevant data resulting from drug usage. For prescriptions the legal framework (e.g., reference pricing) is applied to list all relevant co-payments or discounts (e.g., for pharmaceutical companies) which have to be considered in patented as well as off-patent drugs. The same method is applied for ambulatory services [taking the universal remuneration scheme (EBM) into account] as well as for inpatient stays (discussing certain characteristics of the German DRG system). As a result, for the first time, a pragmatic as well as a practical approach is presented to value resource usage within the German health care system in future studies from the perspective of the statutory health insurance or, in other words, the sickness funds.
Schlagwörter
- Cost analyses, Germany, Methods
ASJC Scopus Sachgebiete
- Medizin (insg.)
- Öffentliche Gesundheit, Umwelt- und Arbeitsmedizin
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: GESUNDHEITSWESEN, Jahrgang 71, Nr. 1, 01.2009, S. 19-23.
Publikation: Beitrag in Fachzeitschrift › Survey Paper › Forschung › Peer-Review
}
TY - JOUR
T1 - Bewertung von Ressourcenverbräuchen im deutschen Gesundheitswesen aus Sicht der Gesetzlichen Krankenversicherung
AU - Braun, S.
AU - Prenzler, A.
AU - Mittendorf, T.
AU - Von Der Schulenburg, J. M.
PY - 2009/1
Y1 - 2009/1
N2 - This paper gives a systematic overview of resource use that is relevant within the German health-care system from the perspective of the statutory health insurance and how these resource uses should be priced in economic analyses. This includes all relevant cost domains from ambulatory and inpatient care as well as a detailed description of relevant data resulting from drug usage. For prescriptions the legal framework (e.g., reference pricing) is applied to list all relevant co-payments or discounts (e.g., for pharmaceutical companies) which have to be considered in patented as well as off-patent drugs. The same method is applied for ambulatory services [taking the universal remuneration scheme (EBM) into account] as well as for inpatient stays (discussing certain characteristics of the German DRG system). As a result, for the first time, a pragmatic as well as a practical approach is presented to value resource usage within the German health care system in future studies from the perspective of the statutory health insurance or, in other words, the sickness funds.
AB - This paper gives a systematic overview of resource use that is relevant within the German health-care system from the perspective of the statutory health insurance and how these resource uses should be priced in economic analyses. This includes all relevant cost domains from ambulatory and inpatient care as well as a detailed description of relevant data resulting from drug usage. For prescriptions the legal framework (e.g., reference pricing) is applied to list all relevant co-payments or discounts (e.g., for pharmaceutical companies) which have to be considered in patented as well as off-patent drugs. The same method is applied for ambulatory services [taking the universal remuneration scheme (EBM) into account] as well as for inpatient stays (discussing certain characteristics of the German DRG system). As a result, for the first time, a pragmatic as well as a practical approach is presented to value resource usage within the German health care system in future studies from the perspective of the statutory health insurance or, in other words, the sickness funds.
KW - Cost analyses
KW - Germany
KW - Methods
UR - http://www.scopus.com/inward/record.url?scp=62549166246&partnerID=8YFLogxK
U2 - 10.1055/s-0028-1102930
DO - 10.1055/s-0028-1102930
M3 - Survey Paper
C2 - 19173145
AN - SCOPUS:62549166246
VL - 71
SP - 19
EP - 23
JO - GESUNDHEITSWESEN
JF - GESUNDHEITSWESEN
SN - 0941-3790
IS - 1
ER -